SanguiBioTech Announces New German Patent Granted on Device for Measuring Viscosity of Microliter Samples.SANTA ANA Santa Ana, city, El Salvador Santa Ana (sän'tä ä`nä), city (1993 pop. 129,873), W El Salvador. It is the second largest city in the country and the commercial and processing center for a sugarcane, coffee, and cattle region. , Calif.--(BUSINESS WIRE)--July 14, 1998--SanguiBioTech Inc. (NASDAQ/BB:SGBI) today announced that a patent on a "Device For Measuring Viscosity Of Microliter microliter /mi·cro·li·ter/ (µL) (mi´kro-le?ter) one millionth (10-6) of a liter. mi·cro·li·ter n. A unit of volume equal to one-millionth (10-6) of a liter. Samples" was granted by the German patent office to its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , GlukoMediTech AG, Mainz, Germany. The new device, which apparently will be used as a "tool" in the development of oxygen carriers/additives, would be useful in the development process. The new apparatus measures viscosity in volumes as low as 50 microliters while common micro viscosimeters need sample volumes of about 3 ml (i.e. 60 times the volume). SanguiBioTech AG is engaged in the development of porcine porcine /por·cine/ (por´sin) pertaining to swine. porcine pertaining to pig. See also hog (1), swine. porcine circovirus 1 a nonpathogenic virus. hemoglobin-based oxygen carriers, especially of so-called blood additives that will help to combat chronic oxygen deficiencies of tissues. Oxygen carriers are, for the time being, rather expensive, and their preparation in great portions is very time-consuming. For this reason, the new apparatus should help to accelerate the development of the new drugs. A U.S. patent on the device has also been filed. SanguiBioTech Inc. is engaged in several facets of biotechnology development. The company has two wholly owned German subsidiaries. SanguiBioTech AG is engaged in the research and development of artificial oxygen carriers based on native hemoglobin to be used as blood substitutes in case of acute blood loss and as blood additives. GlukoMediTech AG is developing an implantable sensor for glucose to be used in diabetic patients, and oxygen and gas sensors also for medial medial /me·di·al/ (me´de-il) 1. situated toward the median plane or midline of the body or a structure. 2. pertaining to the middle layer of structures. me·di·al adj. and environmental use. Its U.S. Diagnostic Division of SanguiBioTech Inc. is developing, manufacturing and marketing, through international distributors, niche in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. immunodiagnostic immunodiagnostic pertaining to diagnosis by immune reactions. test kits. For more information, please visit the Sangui Web site at http://www.investmentpr.com.
CONTACT: Mensch Communications, 888/541-1114 or 619/552-1120
or
SanguiBioTech, AG
Dr. Ulrike Domack, 49-6131-38-2001
fax 49-6131-38-5001
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion